Bringing the fundamentals into focus…
Back to Starling Oncology Inc
How Starling Oncology Inc stacks up
TOI · against 461 other Healthcare companies of similar size
Profitability
24/ 100
Near the bottom of its peers.
Ranked #346 of 462 · scores higher than 23% of peers
Bars: peers in each 10-point band of the profitability score53 peers with a profitability score of 20–29, including TOI · Click a bar to see the companies
Why profitability scores 24?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 84% of peers. Return on invested capital: -32.6% vs peer median 4.7%
- a lower return on assets: weaker than 76% of peers. Return on assets: -12.3% vs peer median 1.7%
- a thinner operating margin: weaker than 73% of peers. Operating margin: -7.2% vs peer median 7.1%
Metric by metric
Position: dot = TOI, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TOI | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 434 reported | -32.6% | 2.0% | 17% | 33% | |
| Operating marginHigher is better · 432 reported | -7.2% | 4.9% | 31% | 33% | |
| Return on assetsHigher is better · 459 reported | -12.3% | 0.9% | 24% | 33% | |
| Return on equityHigher is better · 439 reported | Not reported | 1.2% | — | — | Context only |
| Gross marginHigher is better · 478 reported | 15.1% | 40.3% | 20% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around TOI| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 346 | 775M USD | 24 | 31 | |
| 346 | 508M EUR (≈$559M) | 24 | 21 | |
| 346 | 598M USD | 24 | 49 | |
| 346 | 423M USD | 24 | 29 | |
| 346 | 513M USD | 24 | 31 | |
| 355 | 2.7B CNY (≈$381M) | 23 | 28 | |
| 355 | 6.0B CNY (≈$841M) | 23 | 29 | |
| 355 | 6.8B CNY (≈$959M) | 23 | 43 | |
| 355 | 471M USD | 23 | 21 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score